Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial

Active, not recruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

April 14, 2026

Study Completion Date

April 14, 2026

Conditions
COVID-19
Interventions
PROCEDURE

Extended sampling and procedures

The study patients will give additional blood samples and also urine and faeces samples. Spirometry and additional biometric controls will be performed regularly. Necrobiopsies of various organs from deceased patients will be secured and stored for immunohistological and virological analysis.

Trial Locations (4)

90189

Incectious Diseases Clinic, Umeå

Unknown

Karlstad hospital, Karlstad

Örebro university hospital, Örebro

Västerås hospital, Västerås

All Listed Sponsors
collaborator

Umeå University

OTHER

collaborator

Region Västerbotten

OTHER_GOV

collaborator

Örebro University, Sweden

OTHER

collaborator

Värmland County Council, Sweden

OTHER_GOV

collaborator

Västmanland County Council, Sweden

OTHER_GOV

lead

Johan Normark

OTHER